38 results
8-K
EX-99.1
9rmuw827g z3
25 Mar 24
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
4:05pm
8-K
EX-99.1
av578duwk4d6f
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-1.1
qqvhf7fu8fwd xbrkqs
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
6a7f5 ivp3j
9 Aug 23
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
4:06pm
PRE 14A
sa9c0b
31 Mar 23
Preliminary proxy
4:02pm
424B3
ywsoli9oqrah0qf1av
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
jiy96z
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
8hkwk zvw4ekxgmk
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
zl5 uqbrielp6p8j7lwr
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
k4vijm395bit
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-2.1
hucw7ni6kv
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am